Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19095856.
- Also identified by DOI 10.1213/ane.0b013e318187ed37.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 17-year-old, 55 kg girl was referred to the endocrinology department of a university hospital to determine the etiology of suspected Cushing's syndrome. The patient was treated with oral ketoconazole for 3 days, but a rapid and severe elevation in her liver function test results led to selection of IV etomidate as a therapeutic option. This approach led to decreasing levels of serum cortisol, and the patient was able to tolerate surgical adrenalectomy.
Medical subject headings
- Cushing Syndrome
- Enzyme Inhibitors
- Etomidate
- Hydrocortisone